
2.50 Delayed Data As of Aug 12 | ![]() Today’s Change | 1.93 Today|||52-Week Range 6.50 | -35.73% Year-to-Date |
Arbutus Biopharma (ABUS) Q2 2022 Earnings Call Transcript Aug 04 / MotleyFool.com - Paid Partner Content | Arbutus Biopharma (ABUS) Reports Q2 Loss, Tops Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content |
Previous close | 2.47 |
Today’s open | 2.46 |
Day’s range | 2.46 - 2.54 |
Volume | 23,044 |
Average volume (3 months) | 1,084,364 |
Market cap | $374.9M |
Earnings growth (last year) | +16.84% |
Earnings growth (this year) | +45.06% |
Earnings growth (next 5 years) | +3.00% |
Revenue growth (last year) | +58.92% |
P/E ratio | NM |
Price/Sales | 37.61 |
Price/Book | 2.14 |
---- | ||
--Cassiopea SpA | 0.00 | 0.00% |
EYPTEyePoint Pharmaceuti... | -0.07 | -0.63% |
STROSutro Biopharma Inc | +0.29 | +4.26% |
Next reporting date | November 9, 2022 |
EPS forecast (this quarter) | -$0.13 |
Annual revenue (last year) | $11.0M |
Annual profit (last year) | -$76.2M |
Net profit margin | -693.91% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Warminster, Pennsylvania |